KRAS and pancreatic neoplasm: As a driver gene in pancreatic cancer, KRAS alteration promotes the development of epithelial dysplasia, pancreatic intraepithelial neoplasias (PanINs), and pancreatic mucinous neoplasms (IPMNs) (3).